|Articles|October 1, 2015
Parexel Becomes SCRS Global Impact Partner
Advertisement
The Society for Clinical Research Sites (SCRS), a global trade organization dedicated to representing the interests of clinical research sites, announced a two-year relationship with PAREXEL. PAREXEL will participate as a Global Impact Partner (GIP) and align with 30 other sponsors, CROs, and service providers dedicated to communication and collaboration between industry stakeholders and clinical research sites.
Read the
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Quantifying the Net Financial Value of Deploying Risk-Based Quality Management
2
ACT Brief: RBQM Financial Value Quantified, Sponsor-Configurable AI Systems, and Basket Trials for Rare Pediatrics
3
ACT Brief: Enterprise Risk Management, Execution Architecture for AI, and Rare Pediatric Regulatory Support
4
ACT Brief: Data Pipeline Fragmentation, Vaccine Trial Pressures, and BTK Degrader Partnership
5